[Clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer].

[1]  E. Cortés,et al.  Evaluación de la eficacia y el impacto clínico de la PET-FDG en los pacientes con carcinoma broncopulmonar no microcítico candidatos a cirugía , 2007 .

[2]  C. García,et al.  Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially resectable non-small cell lung cancer , 2007 .

[3]  N. Avril,et al.  Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. , 2007, Gynecologic oncology.

[4]  M. Quinn,et al.  The impact of PET/CT in the management of recurrent ovarian cancer. , 2006, Gynecologic oncology.

[5]  A. Gadducci,et al.  Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature , 2006, International Journal of Gynecologic Cancer.

[6]  F. Fazio,et al.  Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. , 2004, Radiology.

[7]  J. R. Franco-Baux,et al.  Evaluación de la eficacia y del impacto clínico de la PET-FDG en pacientes con sospecha de recurrencia de cáncer colorrectal , 2004 .

[8]  B. Nowak,et al.  2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. , 2001, Gynecologic oncology.

[9]  R. Coleman,et al.  Applications of PET in lung cancer. , 1998, Seminars in nuclear medicine.

[10]  J. Roodenburg,et al.  Detection of unknown occult primary tumors using positron emission tomography , 1998, Cancer.

[11]  M. Tuxen,et al.  Use of CA 125 in follow-up of ovarian cancer , 1996, The Lancet.

[12]  H. Stettner,et al.  Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer , 1991, Gynecologic oncology.

[13]  E. González,et al.  PET con 18FDG en pacientes con cáncer diferenciado de tiroides que presentan niveles elevados de tiroglobulina sérica y rastreos con 131I negativos , 2005 .

[14]  R Yancik,et al.  Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. , 1993, Cancer.

[15]  S. Cannistra,et al.  Cancer of the ovary. , 1993, The New England journal of medicine.